Yahoo Finance Canada's Alicja Siekierska and strategy expert Mark Satov discuss how businesses should approach cybersecurity in a pandemic.
Yahoo Finance Canada's Alicja Siekierska and strategy expert Mark Satov discuss how businesses should approach cybersecurity in a pandemic.
New figures from HMRC show that 347,000 people withdrew from their pensions throughout July, August and September 2020.
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Restaurant Brands International Inc. (NYSE: QSR) pursuant and/or traceable to the Company’s secondary public offerings conducted in August and September 2019 (the "SPOs" or "Offerings"). The lawsuit seeks to recover damages for Restaurant Brands investors under the federal securities laws.
Labaton Sucharow, a nationally ranked shareholder rights firm, is investigating potential securities violations and breach of fiduciary duty claims against drywall and joint compound company USG Corporation (Former NYSE: USG) in connection with its merger with Gebr. Knauf KG.
A national civil liberties group has filed legal notice in the first stage of a suit against the New Brunswick for lack of access to abortion. The Canadian Civil Liberties Association has sent a letter and statement of claim to the province's attorney general. Michael Bryant, the group's executive director, says it wants the province to repeal its regulations on abortion and provide wider access to the procedure.
The "Global Anaplastic Lymphoma Kinase (ALK) Inhibitors Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.
The naval exercise involves the Indian Navy, US Navy, Japan Maritime Self Defence Force and Royal Australian Navy.
Algeria's leaders see Sunday's referendum on a new constitution as a key part of their strategy to move beyond last year's popular unrest, but few people in the streets seem enthused by the vote, and the opposition movement rejects it as a sham. Posters plastered on city walls urging Algerians to back the new constitution draw a comparison with a November 1954 uprising against French colonial rule to it as a moment of national renewal. President Abdelmadjid Tebboune - who was hospitalised in Germany this week - has pushed the referendum as part of his efforts to turn a page on the mass protests that ousted his predecessor and shook the ruling elite.
Mexico’s estimated gross domestic product in the third quarter of the year was 8.6% below that for the same July to September period the previous year, but showed signs of improvement, the country’s statistical agency said Friday. On Friday, the National Statistics and Geography Institute said GDP had risen 12% compared to that previous quarter.
Klopp’s problems intensified when Fabinho, Van Dijk’s defensive replacement, sustained a hamstring injury.
NEW YORK — Stocks are falling in early trading on Friday as Wall Street closes out a punishing week and its first back-to-back monthly loss since March, when worries about the pandemic were first peaking.The S&P 500 was 0.9% lower in early trading, putting it on pace for a 5.3% loss for the week, which would be its worst since March. and a 2.4% drop for the month.The Dow Jones Industrial Average was down 180 points, or 0.7%, at 26,478, as of 9:52 a.m. Eastern time, and the Nasdaq composite was down 1.5%.Worries about whether expectations built too high for some of the stock market’s biggest stars helped drive the losses. Apple, Amazon, Facebook and Google’s parent company are four of the five biggest stocks in the S&P 500 by market value, which gives their movements outsized sway on the index, and they were among the principal forces behind Wall Street’s huge rally since March.All four of them beat analysts’ expectations for earnings in the latest quarter, like the other stock in the Big Five did earlier this week. But like Microsoft, most of them fell following their earnings reports as investors found reasons for concern within their results.Apple dropped 5.4% after investors focused on weaker revenue than expected for its iPhones and sales in China. Amazon fell 4%, and Facebook dropped 4.2%.Twitter, another high-profile tech stock, slumped 17.7% for the largest loss by far among stocks in the S&P 500. It also reported better-than-expected earnings for the latest quarter. Investors were focusing instead on its growth in daily users, which fell short of analysts’ expectations.Google’s parent company, Alphabet, was an outlier and rose 5.7% after reporting growth in digital ad spending.A similar trend has been occurring across the market: Stocks are not getting the same bounce they usually do after reporting better-than-expected results. And they’ve been giving investors plenty of opportunities to do so: With nearly three quarters of the S&P 500 by market value having reported, 84% of companies have beat expectations, according to Credit Suisse.Analysts say that's an indication that expectations may have built too high through the market's big rally and that investors' attention may simply be elsewhere given all the uncertainties sweeping the market.Instead of earnings reports for the last three months, much of the market’s focus has been on what’s to come for the economy when coronavirus counts are rising at a troubling rate across Europe and the United States.Several European governments have already brought back restrictions on businesses to slow the spread of the virus. Even if the heaviest restrictions don’t return in the United States, the worry is the worsening pandemic will nonetheless drive customers away from businesses and undercut their profits.At the same time, Washington has been unable to deliver more aid to the economy. Investors and economists have been lobbying for Congress and the White House to renew supplemental benefits for laid-off workers and other stimulus following the expiration of the last round of stimulus approved earlier this year.On Thursday, though, Democrats and Republicans again blamed the other side for holding up a deal.In markets around the world on Friday, caution was still continuing to dominate. But the moves were not as violent as earlier in the week.A measure of fear in the U.S. stock market, the VIX index, eased by 0.5% after rising the prior day to its highest level since June. The yield on the 10-year Treasury was also holding relatively steady at 0.83%.In European stock markets, France's CAC 40 rose 0.4%, but Germany's DAX lost 0.2%. The FTSE 100 in London slipped 0.1%.In Asia, the Nikkei 225 fell 1.5%, South Korea’s Kospi lost 2.6% and the Hang Seng in Hong Kong dropped 1.9%.Stocks in Shanghai sank 1.5%. China’s ruling party said Thursday its next five-year development plan will emphasize self-reliance in technology.___AP Business Writer Joe McDonald contributed.Stan Choe, The Associated Press
People often leave industry watchdogs to work for the very companies they were previously regulating.
U.S. consumer spending increased more than expected in September, but decreasing benefits for millions of unemployed Americans and a resurgence in COVID-19 cases across the nation could crimp spending in the fourth quarter. The report from the Commerce Department on Friday also showed inflation remaining muted last month, which could allow the Federal Reserve to keep interest rates near zero for a while to aid the recovery from the COVID-19 recession as fiscal stimulus runs out. More than $3 trillion in government pandemic relief, which included a weekly unemployment benefits subsidy, spurred record economic growth in the third quarter.
AM Best has revised the outlooks to stable from negative and affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of "a-" of PT Asuransi Tugu Pratama Indonesia Tbk (TUGU) (Indonesia).
Labaton Sucharow, a global investor rights law firm, announces an investigation on behalf of purchasers of the securities of Navient (NASDAQ: NAVI) and encourages stock, option, and derivative purchasers to contact the firm.
With two and three losses in a row, respectively, RCB and DC still need their eighth win to qualify for the playoffs
The Children’s Commissioner today waded into the row over the closure of Hammersmith Bridge saying it was “extremely disappointing” that pupils will be forced to make arduous trips in the dark to school over winter. The intervention by Anne Longfield came two days after the taskforce set up by Transport Secretary Grant Shapps to speed up repairs to the crossing confirmed that no replacement ferry service will be available until the spring. It was originally hoped that a shuttle between Barnes and Hammersmith could be in place by the time the clocks changed last week.
The "Grant Management Software Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Component, Deployment Type, Organization Size, and End-User, and Geography" report has been added to ResearchAndMarkets.com's offering.
Los Angeles, California--(Newsfile Corp. - October 30, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Coty Inc. (NYSE: COTY) ("Coty" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between October 3, 2016 and May 28, ...
Labaton Sucharow, a global investor rights law firm, announces an investigation on behalf of purchasers of the securities of Raytheon Technologies Corp. (NYSE: RTX) and encourages stock, option, and derivative purchasers to contact the Firm.
Conference call to be held Friday, November 6, at 8:15 a.m. Eastern TimeATLANTA, GA, Oct. 30, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire \-- GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, announces today that it plans to report third quarter 2020 financial results on Thursday, November 5, 2020 after the market closes.Management will host a conference call at 8:15 a.m. ET on Friday, November 6, 2020 to review financial results and provide an update on corporate developments. Following management’s formal remarks, there will be a question and answer session.Participants are asked to pre-register for the call via the following link: https://dpregister.com/sreg/10149661/dc8783c368Please note that registered participants will receive their dial-in number upon registration and will dial directly into the call without delay. Those without Internet access or who are unable to pre-register may dial in by calling 1-866-777-2509 (domestic) or 1-412-317-5413 (international). All callers should dial in approximately 10 minutes prior to the scheduled start time and ask to be joined into the GeoVax Labs call.The conference call will be available through a live webcast found here:https://services.choruscall.com/links/govx201106.htmlA webcast replay of the call will be available approximately one hour after the end of the call through February 6, 2021. The webcast replay can be accessed through the above links or by calling 1-877-344-7529 (domestic) or 1-412-317-0088 (international) and using access code 10149661. The telephonic replay will be available until November 20, 2020.About GeoVaxGeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) based vaccine platform. On this platform, MVA, a large virus capable of carrying several vaccine antigens, expresses proteins that assemble into VLP immunogens within (in vivo) the person receiving the vaccine. The production of VLPs in the person being vaccinated mimics virus production in a natural infection, stimulating both the humoral and cellular arms of the immune system to recognize, prevent, and control the target infection. The MVA-VLP derived vaccines elicit durable immune responses in the host similar to a live-attenuated virus, while providing the safety characteristics of a replication-defective vector. GeoVax’s current development programs are focused on preventive vaccines against COVID-19, HIV, Zika Virus, hemorrhagic fever viruses (Ebola, Sudan, Marburg, and Lassa), and malaria, as well as therapeutic vaccines against multiple cancers. The Company has designed a preventive HIV vaccine candidate to fight against the subtype of HIV prevalent in the commercial markets of the Americas, Western Europe, Japan, and Australia. Human clinical trials for this program are managed by the HIV Vaccine Trials Network (HVTN) with the support of the National Institutes of Health (NIH). GeoVax’s HIV vaccine candidate is also part of two separate collaborative efforts to apply its innovative gene therapy approach toward a functional cure for HIV.Cautionary Note Regarding Forward-Looking StatementsThis release contains forward-looking statements regarding the timing of the release of GeoVax’s financial results and earnings conference call and the earnings release and call are expected to discuss forward-looking statements regarding GeoVax’s ability to implement its business plan, expected revenues and future success. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax can develop and manufacture its vaccines with the desired characteristics in a timely manner, GeoVax’s vaccines will be safe for human use, GeoVax’s vaccines will effectively prevent targeted infections in humans, GeoVax’s vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete vaccine development, there is development of competitive products that may be more effective or easier to use than GeoVax’s products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, the impact of the COVID-19 pandemic continues, and other factors, over which GeoVax has no control.Further information on our risk factors is contained in our registration statement on Form S-1 (File No. 333-239958) that we have filed with the SEC and the final prospectus. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.GeoVax Labs, Inc. 678-384-7220 email@example.com